Shares of Healthways Inc. (NASDAQ:HWAY) have earned an average rating of “Buy” from the seven research firms that are presently covering the company. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $26.50.
A number of research analysts have issued reports on HWAY shares. Zacks Investment Research raised Healthways from a “hold” rating to a “buy” rating and set a $20.00 target price for the company in a research note on Monday, August 8th. Barclays PLC raised Healthways from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $12.00 to $27.00 in a research note on Monday, August 22nd. Jefferies Group boosted their target price on Healthways from $13.00 to $18.50 and gave the company a “hold” rating in a research note on Thursday, August 4th. Barrington Research reissued an “outperform” rating and issued a $30.00 target price (up from $29.00) on shares of Healthways in a research note on Thursday. Finally, FBR & Co boosted their price target on Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, August 10th.
In related news, Director Mary Jane England sold 3,816 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $24.78, for a total transaction of $94,560.48. Following the sale, the director now owns 39,068 shares in the company, valued at $968,105.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 14.01% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the company. Waddell & Reed Financial Inc. bought a new stake in Healthways during the second quarter valued at about $8,636,000. Rutabaga Capital Management LLC MA raised its stake in Healthways by 359.7% in the second quarter. Rutabaga Capital Management LLC MA now owns 866,087 shares of the company’s stock valued at $10,003,000 after buying an additional 677,677 shares during the last quarter. Eagle Asset Management Inc. bought a new stake in Healthways during the third quarter valued at about $15,530,000. Dimensional Fund Advisors LP raised its stake in Healthways by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 3,058,854 shares of the company’s stock valued at $35,330,000 after buying an additional 230,768 shares during the last quarter. Finally, Vanguard Group Inc. raised its stake in Healthways by 6.0% in the second quarter. Vanguard Group Inc. now owns 2,622,631 shares of the company’s stock valued at $30,292,000 after buying an additional 148,879 shares during the last quarter. Institutional investors and hedge funds own 92.52% of the company’s stock.
Shares of Healthways (NASDAQ:HWAY) traded up 0.08% on Friday, hitting $24.98. The stock had a trading volume of 408,797 shares. The stock’s market capitalization is $917.72 million. Healthways has a one year low of $9.18 and a one year high of $27.30. The firm’s 50 day moving average is $25.34 and its 200-day moving average is $16.38.
Healthways (NASDAQ:HWAY) last posted its earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.53. Healthways had a positive return on equity of 8.83% and a negative net margin of 31.32%. The firm earned $125 million during the quarter, compared to analysts’ expectations of $186.88 million. During the same period in the previous year, the firm earned $0.11 earnings per share. The company’s revenue was up 10.2% on a year-over-year basis. Equities research analysts expect that Healthways will post $2.11 earnings per share for the current fiscal year.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.